Cerebral Hemodynamic Impairment and Cognitive Dysfunction in APOE4 Carriers With Asymptomatic Carotid Artery Stenosis/Occlusion
Our previous preclinical study demonstrated that -targeted replacement mice exhibit more severe cerebral hypoperfusion and cognitive impairment than -targeted replacement mice with carotid artery stenosis due to neurovascular dysfunction. Therefore, we clinically investigate whether contributes to c...
Saved in:
Published in | Journal of the American Heart Association Vol. 14; no. 6; p. e039210 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
John Wiley and Sons Inc
18.03.2025
Wiley |
Subjects | |
Online Access | Get full text |
ISSN | 2047-9980 2047-9980 |
DOI | 10.1161/JAHA.124.039210 |
Cover
Abstract | Our previous preclinical study demonstrated that
-targeted replacement mice exhibit more severe cerebral hypoperfusion and cognitive impairment than
-targeted replacement mice with carotid artery stenosis due to neurovascular dysfunction. Therefore, we clinically investigate whether
contributes to cerebral hemodynamic and cognitive impairment in subjects with asymptomatic carotid artery stenosis or occlusion.
A cross-sectional observational study was conducted between January 2017 and March 2022. In a primary analysis, 91 subjects (114 affected cerebral hemispheres) with asymptomatic carotid artery stenosis or occlusion who underwent neuropsychological examinations and
O-gas positron emission tomography were included to examine associations of
with cognitive impairment and cerebral hemodynamic impairment. A sensitivity analysis was performed with 161 subjects (201 affected cerebral hemispheres) who underwent
O-gas positron emission tomography scan. In the primary analysis, 20 (22.0%) subjects were
carriers.
was an independent risk factor of lower cerebral blood flow in the anterior circulation territory (β=-0.058 [95% CI, -0.098 to -0.018],
=0.005) and short-term memory impairment in Alzheimer's Disease Assessment Scale-Cognitive Subscale 13 (β=1.16 [95% CI, 0.009-2.30],
=0.048) in a multivariable linear regression analysis. In the sensitivity analysis, 31 (19.3%) subjects carried
, which was an independent risk factor of lower cerebral blood flow (β=-0.048 [95% CI, -0.079 to -0.012],
=0.003) in the anterior circulation territory.
may confer an increased risk of decreased cerebral blood flow accompanied by memory impairment in asymptomatic carotid artery stenosis or occlusion consistent with our experimental study.
genotyping in such subjects may be useful for early detection of disease severity. |
---|---|
AbstractList | Background Our previous preclinical study demonstrated that APOE4‐targeted replacement mice exhibit more severe cerebral hypoperfusion and cognitive impairment than APOE3‐targeted replacement mice with carotid artery stenosis due to neurovascular dysfunction. Therefore, we clinically investigate whether APOE4 contributes to cerebral hemodynamic and cognitive impairment in subjects with asymptomatic carotid artery stenosis or occlusion. Methods and Results A cross‐sectional observational study was conducted between January 2017 and March 2022. In a primary analysis, 91 subjects (114 affected cerebral hemispheres) with asymptomatic carotid artery stenosis or occlusion who underwent neuropsychological examinations and 15O‐gas positron emission tomography were included to examine associations of APOE4 with cognitive impairment and cerebral hemodynamic impairment. A sensitivity analysis was performed with 161 subjects (201 affected cerebral hemispheres) who underwent 15O‐gas positron emission tomography scan. In the primary analysis, 20 (22.0%) subjects were APOE4 carriers. APOE4 was an independent risk factor of lower cerebral blood flow in the anterior circulation territory (β=−0.058 [95% CI, −0.098 to −0.018], P=0.005) and short‐term memory impairment in Alzheimer's Disease Assessment Scale‐Cognitive Subscale 13 (β=1.16 [95% CI, 0.009–2.30], P=0.048) in a multivariable linear regression analysis. In the sensitivity analysis, 31 (19.3%) subjects carried APOE4, which was an independent risk factor of lower cerebral blood flow (β=−0.048 [95% CI, −0.079 to −0.012], P=0.003) in the anterior circulation territory. Conclusions APOE4 may confer an increased risk of decreased cerebral blood flow accompanied by memory impairment in asymptomatic carotid artery stenosis or occlusion consistent with our experimental study. APOE genotyping in such subjects may be useful for early detection of disease severity. Our previous preclinical study demonstrated that APOE4-targeted replacement mice exhibit more severe cerebral hypoperfusion and cognitive impairment than APOE3-targeted replacement mice with carotid artery stenosis due to neurovascular dysfunction. Therefore, we clinically investigate whether APOE4 contributes to cerebral hemodynamic and cognitive impairment in subjects with asymptomatic carotid artery stenosis or occlusion.BACKGROUNDOur previous preclinical study demonstrated that APOE4-targeted replacement mice exhibit more severe cerebral hypoperfusion and cognitive impairment than APOE3-targeted replacement mice with carotid artery stenosis due to neurovascular dysfunction. Therefore, we clinically investigate whether APOE4 contributes to cerebral hemodynamic and cognitive impairment in subjects with asymptomatic carotid artery stenosis or occlusion.A cross-sectional observational study was conducted between January 2017 and March 2022. In a primary analysis, 91 subjects (114 affected cerebral hemispheres) with asymptomatic carotid artery stenosis or occlusion who underwent neuropsychological examinations and 15O-gas positron emission tomography were included to examine associations of APOE4 with cognitive impairment and cerebral hemodynamic impairment. A sensitivity analysis was performed with 161 subjects (201 affected cerebral hemispheres) who underwent 15O-gas positron emission tomography scan. In the primary analysis, 20 (22.0%) subjects were APOE4 carriers. APOE4 was an independent risk factor of lower cerebral blood flow in the anterior circulation territory (β=-0.058 [95% CI, -0.098 to -0.018], P=0.005) and short-term memory impairment in Alzheimer's Disease Assessment Scale-Cognitive Subscale 13 (β=1.16 [95% CI, 0.009-2.30], P=0.048) in a multivariable linear regression analysis. In the sensitivity analysis, 31 (19.3%) subjects carried APOE4, which was an independent risk factor of lower cerebral blood flow (β=-0.048 [95% CI, -0.079 to -0.012], P=0.003) in the anterior circulation territory.METHODS AND RESULTSA cross-sectional observational study was conducted between January 2017 and March 2022. In a primary analysis, 91 subjects (114 affected cerebral hemispheres) with asymptomatic carotid artery stenosis or occlusion who underwent neuropsychological examinations and 15O-gas positron emission tomography were included to examine associations of APOE4 with cognitive impairment and cerebral hemodynamic impairment. A sensitivity analysis was performed with 161 subjects (201 affected cerebral hemispheres) who underwent 15O-gas positron emission tomography scan. In the primary analysis, 20 (22.0%) subjects were APOE4 carriers. APOE4 was an independent risk factor of lower cerebral blood flow in the anterior circulation territory (β=-0.058 [95% CI, -0.098 to -0.018], P=0.005) and short-term memory impairment in Alzheimer's Disease Assessment Scale-Cognitive Subscale 13 (β=1.16 [95% CI, 0.009-2.30], P=0.048) in a multivariable linear regression analysis. In the sensitivity analysis, 31 (19.3%) subjects carried APOE4, which was an independent risk factor of lower cerebral blood flow (β=-0.048 [95% CI, -0.079 to -0.012], P=0.003) in the anterior circulation territory.APOE4 may confer an increased risk of decreased cerebral blood flow accompanied by memory impairment in asymptomatic carotid artery stenosis or occlusion consistent with our experimental study. APOE genotyping in such subjects may be useful for early detection of disease severity.CONCLUSIONSAPOE4 may confer an increased risk of decreased cerebral blood flow accompanied by memory impairment in asymptomatic carotid artery stenosis or occlusion consistent with our experimental study. APOE genotyping in such subjects may be useful for early detection of disease severity. Our previous preclinical study demonstrated that -targeted replacement mice exhibit more severe cerebral hypoperfusion and cognitive impairment than -targeted replacement mice with carotid artery stenosis due to neurovascular dysfunction. Therefore, we clinically investigate whether contributes to cerebral hemodynamic and cognitive impairment in subjects with asymptomatic carotid artery stenosis or occlusion. A cross-sectional observational study was conducted between January 2017 and March 2022. In a primary analysis, 91 subjects (114 affected cerebral hemispheres) with asymptomatic carotid artery stenosis or occlusion who underwent neuropsychological examinations and O-gas positron emission tomography were included to examine associations of with cognitive impairment and cerebral hemodynamic impairment. A sensitivity analysis was performed with 161 subjects (201 affected cerebral hemispheres) who underwent O-gas positron emission tomography scan. In the primary analysis, 20 (22.0%) subjects were carriers. was an independent risk factor of lower cerebral blood flow in the anterior circulation territory (β=-0.058 [95% CI, -0.098 to -0.018], =0.005) and short-term memory impairment in Alzheimer's Disease Assessment Scale-Cognitive Subscale 13 (β=1.16 [95% CI, 0.009-2.30], =0.048) in a multivariable linear regression analysis. In the sensitivity analysis, 31 (19.3%) subjects carried , which was an independent risk factor of lower cerebral blood flow (β=-0.048 [95% CI, -0.079 to -0.012], =0.003) in the anterior circulation territory. may confer an increased risk of decreased cerebral blood flow accompanied by memory impairment in asymptomatic carotid artery stenosis or occlusion consistent with our experimental study. genotyping in such subjects may be useful for early detection of disease severity. |
Author | Hattori, Yorito Ogata, Soshiro Nakaoku, Yuriko Nishimura, Kunihiro Iida, Hidehiro Kakino, Yoshinori Ihara, Masafumi |
AuthorAffiliation | 1 Department of Neurology National Cerebral and Cardiovascular Center Suita, Osaka Japan 2 Department of Preemptive Medicine for Dementia National Cerebral and Cardiovascular Center Suita, Osaka Japan 3 Department of Preventive Medicine and Epidemiology National Cerebral and Cardiovascular Center Suita, Osaka Japan 4 Turku PET Centre University of Turku and Turku General Hospital Turku Finland |
AuthorAffiliation_xml | – name: 2 Department of Preemptive Medicine for Dementia National Cerebral and Cardiovascular Center Suita, Osaka Japan – name: 1 Department of Neurology National Cerebral and Cardiovascular Center Suita, Osaka Japan – name: 4 Turku PET Centre University of Turku and Turku General Hospital Turku Finland – name: 3 Department of Preventive Medicine and Epidemiology National Cerebral and Cardiovascular Center Suita, Osaka Japan |
Author_xml | – sequence: 1 givenname: Yoshinori surname: Kakino fullname: Kakino, Yoshinori – sequence: 2 givenname: Yorito orcidid: 0000-0002-1495-4433 surname: Hattori fullname: Hattori, Yorito – sequence: 3 givenname: Soshiro orcidid: 0000-0002-0100-376X surname: Ogata fullname: Ogata, Soshiro – sequence: 4 givenname: Yuriko orcidid: 0000-0002-3100-574X surname: Nakaoku fullname: Nakaoku, Yuriko – sequence: 5 givenname: Kunihiro orcidid: 0000-0002-0639-0949 surname: Nishimura fullname: Nishimura, Kunihiro – sequence: 6 givenname: Hidehiro orcidid: 0000-0002-7914-3068 surname: Iida fullname: Iida, Hidehiro – sequence: 7 givenname: Masafumi orcidid: 0000-0002-7102-4048 surname: Ihara fullname: Ihara, Masafumi |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40079311$$D View this record in MEDLINE/PubMed |
BookMark | eNpVks9v0zAUxyM0xMbYmRvykUtb_0qcnFCUDVo0qUiAOFqO_dJ5SuxiO5N64l_HpWPafLCf_L76fK3n79vizHkHRfGe4CUhFVl9bdftklC-xKyhBL8qLijmYtE0NT57Vp8XVzHe47wqKljZvCnOOcaiYYRcFH86CNAHNaI1TN4cnJqsRptpr2yYwCWknEGd3zmb7AOg60McZqeT9Q5Zh9pv2xuOOhWChRDRL5vuUBsP0z75SaUMyi2frEFtSBAO6HsC56ONq63W4xwz5V3xelBjhKvH87L4-fnmR7de3G6_bLr2dqE5qdJCV0CMGnhJcS3yxnpR9blQtKkqXPZCq6bWlJGSNkAIGKoHwY1hxHBDQbHLYnPiGq_u5T7YSYWD9MrKfxc-7KQK-cUjSMwNZ0xURuujeVMDCNoz3pclLrmpM-vTibWf-wmMzmPKA3wBfdlx9k7u_IMklDBa1WUmfHwkBP97hpjkZKOGcVQO_BwlI0IQ3pAKZ-mH52ZPLv-_MAtWJ4EOPsYAw5OEYHnMiTzmJHtzecoJ-wvIe7CU |
Cites_doi | 10.1016/j.neuropsychologia.2008.03.005 10.5853/jos.2023.02733 10.3233/JAD-142874 10.1007/s00401-011-0925-9 10.1159/000090791 10.1109/TNS.2002.807869 10.3389/fpsyg.2012.00301 10.1038/s41593-024-01757-6 10.1002/14651858.CD010632.pub2 10.1177/23969873211026990 10.1038/sj.jcbfm.9600118 10.1212/WNL.0b013e318211c3ae 10.1186/s40658-018-0236-5 10.3389/fncir.2022.916499 10.1136/jnis.2010.002345 10.1016/S1474-4422(21)00359-8 10.1002/trc2.12285 10.1186/s12872-019-1127-y 10.1038/s41467-018-06301-2 10.1016/j.jvs.2005.02.044 10.1371/journal.pone.0146890 10.1097/00002093-199700112-00003 10.3174/ajnr.A6219 10.1088/0031-9155/59/18/5593 10.1007/s13139-019-00633-7 10.1212/WNL.0b013e31824365d3 10.3233/JAD-191073 10.3174/ajnr.A5068 10.1001/archneur.1985.04060030081013 10.1016/j.jstrokecerebrovasdis.2013.03.013 10.1186/s12872-019-1194-0 10.1007/s00401-016-1547-z 10.1038/s41598-019-50681-4 10.1212/WNL.0b013e318295d71a 10.1111/j.1532-5415.2005.53221.x 10.2214/ajr.149.2.351 10.1038/s41598-022-09129-5 10.3174/ajnr.A3799 10.1007/s11682-023-00764-8 10.3389/fpsyg.2018.00765 10.1016/j.jvs.2017.04.038 10.1007/s00401-018-1862-7 10.1161/STROKEAHA.124.047160 |
ContentType | Journal Article |
Copyright | 2025 The Author(s). Published on behalf of the American Heart Association, Inc., by Wiley. |
Copyright_xml | – notice: 2025 The Author(s). Published on behalf of the American Heart Association, Inc., by Wiley. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.1161/JAHA.124.039210 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | APOE4 and Carotid Artery Stenosis/Occlusion |
EISSN | 2047-9980 |
ExternalDocumentID | oai_doaj_org_article_04d43376dccc41698ee72b34b55054d8 PMC12132685 40079311 10_1161_JAHA_124_039210 |
Genre | Journal Article Observational Study |
GroupedDBID | 0R~ 1OC 24P 53G 5VS 8-1 AAMMB AAYXX AAZKR ACCMX ACGFO ACXQS ADBBV ADKYN ADZMN AEFGJ AEGXH AENEX AGXDD AIAGR AIDQK AIDYY ALAGY ALMA_UNASSIGNED_HOLDINGS AOIJS AVUZU BAWUL BCNDV CITATION DIK EBS EMOBN GODZA GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 RAH RNS RPM WIN CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c416t-c6e1daf4520875203b76b752a296605b7ca98c231529e11ed2cf74dd31d4d2ea3 |
IEDL.DBID | DOA |
ISSN | 2047-9980 |
IngestDate | Wed Aug 27 01:25:52 EDT 2025 Thu Aug 21 18:25:42 EDT 2025 Fri Sep 05 07:52:30 EDT 2025 Mon Jul 21 06:01:37 EDT 2025 Tue Aug 05 12:03:07 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | cerebral blood flow carotid artery stenosis memory APOE4 carotid artery occlusion |
Language | English |
License | This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c416t-c6e1daf4520875203b76b752a296605b7ca98c231529e11ed2cf74dd31d4d2ea3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3 This article was sent to Neel S. Singhal, MD, PhD, Associate Editor, for review by expert referees, editorial decision, and final disposition. Supplemental Material is available at https://www.ahajournals.org/doi/suppl/10.1161/JAHA.124.039210 Y. Kakino and Y. Hattori contributed equally to this article. For Sources of Funding and Disclosures, see page 12. |
ORCID | 0000-0002-1495-4433 0000-0002-7102-4048 0000-0002-0100-376X 0000-0002-0639-0949 0000-0002-7914-3068 0000-0002-3100-574X |
OpenAccessLink | https://doaj.org/article/04d43376dccc41698ee72b34b55054d8 |
PMID | 40079311 |
PQID | 3177149160 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_04d43376dccc41698ee72b34b55054d8 pubmedcentral_primary_oai_pubmedcentral_nih_gov_12132685 proquest_miscellaneous_3177149160 pubmed_primary_40079311 crossref_primary_10_1161_JAHA_124_039210 |
PublicationCentury | 2000 |
PublicationDate | 2025-03-18 |
PublicationDateYYYYMMDD | 2025-03-18 |
PublicationDate_xml | – month: 03 year: 2025 text: 2025-03-18 day: 18 |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Hoboken |
PublicationTitle | Journal of the American Heart Association |
PublicationTitleAlternate | J Am Heart Assoc |
PublicationYear | 2025 |
Publisher | John Wiley and Sons Inc Wiley |
Publisher_xml | – name: John Wiley and Sons Inc – name: Wiley |
References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_48_2 e_1_3_2_29_2 e_1_3_2_41_2 e_1_3_2_40_2 e_1_3_2_20_2 e_1_3_2_43_2 e_1_3_2_42_2 e_1_3_2_22_2 e_1_3_2_45_2 e_1_3_2_23_2 e_1_3_2_44_2 e_1_3_2_24_2 e_1_3_2_47_2 e_1_3_2_25_2 e_1_3_2_46_2 Iida H (e_1_3_2_21_2) 1993; 34 e_1_3_2_9_2 e_1_3_2_15_2 Koga M (e_1_3_2_16_2) 2001; 22 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_39_2 e_1_3_2_19_2 Rosner J (e_1_3_2_28_2) 2023 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_2_2 e_1_3_2_14_2 e_1_3_2_35_2 |
References_xml | – ident: e_1_3_2_36_2 doi: 10.1016/j.neuropsychologia.2008.03.005 – ident: e_1_3_2_27_2 doi: 10.5853/jos.2023.02733 – volume: 34 start-page: 1333 year: 1993 ident: e_1_3_2_21_2 article-title: Modeling approach to eliminate the need to separate arterial plasma in oxygen‐15 inhalation positron emission tomography publication-title: J Nucl Med – ident: e_1_3_2_47_2 doi: 10.3233/JAD-142874 – ident: e_1_3_2_41_2 doi: 10.1007/s00401-011-0925-9 – ident: e_1_3_2_2_2 doi: 10.1159/000090791 – ident: e_1_3_2_20_2 doi: 10.1109/TNS.2002.807869 – ident: e_1_3_2_35_2 doi: 10.3389/fpsyg.2012.00301 – ident: e_1_3_2_13_2 doi: 10.1038/s41593-024-01757-6 – ident: e_1_3_2_48_2 doi: 10.1002/14651858.CD010632.pub2 – ident: e_1_3_2_17_2 doi: 10.1177/23969873211026990 – ident: e_1_3_2_19_2 doi: 10.1038/sj.jcbfm.9600118 – ident: e_1_3_2_31_2 doi: 10.1212/WNL.0b013e318211c3ae – ident: e_1_3_2_18_2 doi: 10.1186/s40658-018-0236-5 – ident: e_1_3_2_32_2 doi: 10.3389/fncir.2022.916499 – ident: e_1_3_2_25_2 doi: 10.1136/jnis.2010.002345 – ident: e_1_3_2_4_2 doi: 10.1016/S1474-4422(21)00359-8 – ident: e_1_3_2_40_2 doi: 10.1002/trc2.12285 – ident: e_1_3_2_8_2 doi: 10.1186/s12872-019-1127-y – ident: e_1_3_2_12_2 doi: 10.1038/s41467-018-06301-2 – ident: e_1_3_2_11_2 – ident: e_1_3_2_15_2 doi: 10.1016/j.jvs.2005.02.044 – ident: e_1_3_2_39_2 doi: 10.1371/journal.pone.0146890 – ident: e_1_3_2_24_2 doi: 10.1097/00002093-199700112-00003 – ident: e_1_3_2_37_2 doi: 10.3174/ajnr.A6219 – ident: e_1_3_2_22_2 doi: 10.1088/0031-9155/59/18/5593 – ident: e_1_3_2_3_2 doi: 10.1007/s13139-019-00633-7 – ident: e_1_3_2_6_2 doi: 10.1212/WNL.0b013e31824365d3 – ident: e_1_3_2_44_2 doi: 10.3233/JAD-191073 – ident: e_1_3_2_46_2 doi: 10.3174/ajnr.A5068 – ident: e_1_3_2_33_2 doi: 10.1001/archneur.1985.04060030081013 – ident: e_1_3_2_30_2 doi: 10.1016/j.jstrokecerebrovasdis.2013.03.013 – ident: e_1_3_2_29_2 doi: 10.1186/s12872-019-1194-0 – volume-title: StatPearls year: 2023 ident: e_1_3_2_28_2 – ident: e_1_3_2_10_2 doi: 10.1007/s00401-016-1547-z – ident: e_1_3_2_42_2 doi: 10.1038/s41598-019-50681-4 – ident: e_1_3_2_5_2 doi: 10.1212/WNL.0b013e318295d71a – ident: e_1_3_2_23_2 doi: 10.1111/j.1532-5415.2005.53221.x – volume: 22 start-page: 413 year: 2001 ident: e_1_3_2_16_2 article-title: Diagnosis of internal carotid artery stenosis greater than 70% with power Doppler duplex sonography publication-title: Am J Neuroradiol – ident: e_1_3_2_26_2 doi: 10.2214/ajr.149.2.351 – ident: e_1_3_2_14_2 doi: 10.1038/s41598-022-09129-5 – ident: e_1_3_2_45_2 doi: 10.3174/ajnr.A3799 – ident: e_1_3_2_38_2 doi: 10.1007/s11682-023-00764-8 – ident: e_1_3_2_34_2 doi: 10.3389/fpsyg.2018.00765 – ident: e_1_3_2_7_2 doi: 10.1016/j.jvs.2017.04.038 – ident: e_1_3_2_43_2 doi: 10.1007/s00401-018-1862-7 – ident: e_1_3_2_9_2 doi: 10.1161/STROKEAHA.124.047160 |
SSID | ssj0000627359 |
Score | 2.3814402 |
Snippet | Our previous preclinical study demonstrated that
-targeted replacement mice exhibit more severe cerebral hypoperfusion and cognitive impairment than
-targeted... Our previous preclinical study demonstrated that APOE4-targeted replacement mice exhibit more severe cerebral hypoperfusion and cognitive impairment than... Background Our previous preclinical study demonstrated that APOE4‐targeted replacement mice exhibit more severe cerebral hypoperfusion and cognitive impairment... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | e039210 |
SubjectTerms | Aged APOE4 Apolipoprotein E4 - genetics Asymptomatic Diseases carotid artery occlusion carotid artery stenosis Carotid Stenosis - complications Carotid Stenosis - diagnosis Carotid Stenosis - diagnostic imaging Carotid Stenosis - genetics Carotid Stenosis - physiopathology Carotid Stenosis - psychology cerebral blood flow Cerebrovascular Circulation - physiology Cognition Cognitive Dysfunction - diagnosis Cognitive Dysfunction - etiology Cognitive Dysfunction - genetics Cognitive Dysfunction - physiopathology Cross-Sectional Studies Female Hemodynamics Heterozygote Humans Male memory Middle Aged Original Research Positron-Emission Tomography Risk Factors |
SummonAdditionalLinks | – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQIiEuiDflJSNx4JLdxHYc54BQKbsqK5VFgoq9WX6FjdRNliSV6Im_zkySLhT1yC2Kk4zjL-OZ8TjfEPJaWSMcZhiDkiISnBWRKQToVWx9apSzpierXnyS86U4PU_P_5QDGgew3RvaYT2pZbM6_Plj8w4U_m2v8DI5Op3OcU1PHIJMhr9b3QSzJDESW4y-_jAtg6VO85HeZ899O5apJ_Df53X-u3nyL2t0cpfcGd1IOh1wv0duhOo-ubUYE-UPyK9ZaDAlvKLzcFn7oew8_Qi6Xza4HkhN5elsu3WIfti0aOAQJFpWdPr57FjQmWmwnF1Lv5XdBZ22m8urru4ZXrGp7kqP8kOzoV86pBwv26Mz51ZrXH97SJYnx19n82istRA5GKsucjIkHlBKGVLcs5jbTFo4AKgkRDw2cyZXDpzBlOUhSYJnrsiE9zzxwrNg-CNyUNVVeEJo4V1ucsOtt5mIRaGU9TH3-OxCBusn5M12nPXVQKmh-1BEJhoh0QCJHiCZkPeIw_VlyIXdn6ib73pULR0LLzjMk945fJdchZAxy4XF4Et4NSGvtihq0B1MiJgq1OtWg--UQYSYSBD0eED1WhTWi895kkyI2sF7py-7LVV50fNzI0sekyp9-j96_4zcZlhyGLcQqufkoGvW4QX4QZ192X_fvwFflghV priority: 102 providerName: Scholars Portal |
Title | Cerebral Hemodynamic Impairment and Cognitive Dysfunction in APOE4 Carriers With Asymptomatic Carotid Artery Stenosis/Occlusion |
URI | https://www.ncbi.nlm.nih.gov/pubmed/40079311 https://www.proquest.com/docview/3177149160 https://pubmed.ncbi.nlm.nih.gov/PMC12132685 https://doaj.org/article/04d43376dccc41698ee72b34b55054d8 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh9JL6bubPlChh17ctWVZlo_bbcI2sE2hDc1NSBqZGBI72N7DnvrXO2N7w24p9NKLMZaxBn0az6fXN4y9185KTyuMQSsZyVSUkS0l-lXsILPaOzuIVa-_qtWFPLvMLvdSfdGesFEeeGy4eSxBpugF4L1H8lDoEHLhUumIWksYjvnGRbw3mBr_wRiWs2LS8kFWMz9brGjiT35EwwSdl90LQ4Na_98o5p87JfdCz-kj9nDijHwx2vqY3Qv1E3Z_Pa2KP2W_lqGl9d9rvgo3DYw55vkXdPSqpck_bmvgy90-If5521E0I0R4VfPFt_MTyZe2pdx1Hf9Z9Vd80W1vbvtmkHOloqavgOoP7ZZ_70lfvOrm595fb2iy7Rm7OD35sVxFU2KFiJqwj7wKCSAkmSA9exGnLlcObxAXhcMbl3tbaI_MLxNFSJIAwpe5BEgTkCCCTZ-zo7qpw0vGS_CFLWzqwOUylqXWDuIU6NulCg5m7MOunc3tqJ9hhnGHSgxBYhASM0IyY58Ih7vXSPh6eIDdwUzdwfyrO8zYux2KBh2FVj9sHZpNZ5Ao5TgcTBRW9GJE9a4qSg5fpEkyY_oA7wNbDkvq6moQ4yZJPKF0dvw_rH_FHgjKL0z7BfVrdtS3m_AGSU_v3g79G69rqX8DYSABxw |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cerebral+Hemodynamic+Impairment+and+Cognitive+Dysfunction+in+APOE4+Carriers+With+Asymptomatic+Carotid+Artery+Stenosis%2FOcclusion&rft.jtitle=Journal+of+the+American+Heart+Association&rft.au=Yoshinori+Kakino&rft.au=Yorito+Hattori&rft.au=Soshiro+Ogata&rft.au=Yuriko+Nakaoku&rft.date=2025-03-18&rft.pub=Wiley&rft.eissn=2047-9980&rft.volume=14&rft.issue=6&rft_id=info:doi/10.1161%2FJAHA.124.039210&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_04d43376dccc41698ee72b34b55054d8 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2047-9980&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2047-9980&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2047-9980&client=summon |